Dr.SleepRoch said:

Lp(a) and cardiovascular risk: a nuance that matters.

I read this differently from Dr.SleepRoch, on substance rather than tone. The "earlier than weight loss explains" argument is weaker than this thread makes it sound. Blood pressure and inflammatory markers move fast and are downstream of early weight loss, so the mechanism is not as cleanly separable as the summaries imply.

pete_manc_UK said:

Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

Metabolic syndrome resolution on cardiovascular risk: I went from meeting 4 of 5 diagnostic criteria to meeting ZERO after 9 months of treatment.

The 5 criteria (and my journey):

1. Waist circumference: 48" → 34" ✅ Resolved
2. Triglycerides: 256 → 116 ✅ Resolved
3. HDL: 32 → 58 ✅ Resolved
4. Blood pressure: 146/94 → 119/73 ✅ Resolved
5. Fasting glucose: 121 → 84 ✅ Resolved

Metabolic syndrome reversal is, in my view, the most medically significant outcome of GLP-1 therapy.

Dr.GastroMayo said:

The "earlier than weight loss explains" argument is weaker than this thread makes it sound.

Dr.GastroMayo said:

...cardiovascular risk is just another fad...

I understand the skepticism — we've all seen "miracle" weight loss solutions come and go. But consider what makes GLP-1 agonists different:

• Phase 3 RCTs with thousands of participants (not 20-person pilot studies)
• Published in NEJM, JAMA, Lancet (not press releases)
• Replicated across multiple independent research groups
• Proven cardiovascular and renal benefits beyond weight loss
• Biological mechanism fully characterized at the receptor level

This isn't a fad — it's a new drug class supported by the highest level of clinical evidence. The comparison to past fads is understandable but inappropriate.

One thing that is still open after GraceAZ_72’s answer:

Was that from a primary source or from a summary of one?

paige_pharma said:

Dr.GastroMayo said: ...cardiovascular risk is just another fad...

Senior perspective on cardiovascular risk: I'm 65 years old and started this journey skeptically. My endocrinologist recommended it after years of failed interventions.

11 months later: down 58 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.